Journey Medical Corp (DERM)
5.135
-0.02
(-0.29%)
USD |
NASDAQ |
Nov 14, 10:57
Journey Medical Shareholders Equity (Quarterly): 11.30M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.30M |
| March 31, 2024 | 12.95M |
| December 31, 2023 | 20.35M |
| September 30, 2023 | 17.37M |
| June 30, 2023 | 0.005M |
| March 31, 2023 | 7.492M |
| December 31, 2022 | 16.98M |
| Date | Value |
|---|---|
| September 30, 2022 | 26.18M |
| June 30, 2022 | 34.80M |
| March 31, 2022 | 41.44M |
| December 31, 2021 | 42.04M |
| September 30, 2021 | -11.71M |
| June 30, 2021 | -0.792M |
| December 31, 2020 | 10.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.71M
Minimum
Sep 2021
42.04M
Maximum
Dec 2021
16.34M
Average
14.97M
Median
Shareholders Equity (Quarterly) Benchmarks
| Fortress Biotech Inc | 17.88M |
| Heron Therapeutics Inc | -37.94M |
| Checkpoint Therapeutics Inc | -15.75M |
| Avenue Therapeutics Inc | 4.764M |
| Eton Pharmaceuticals Inc | 13.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.19M |
| Total Liabilities (Quarterly) | 53.89M |
| Debt to Equity Ratio | 1.748 |
| Current Ratio | 1.361 |
| Net Debt Paydown Yield | 0.55% |